Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms - Top-Institutions - MDSpire

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

  • By

  • Yudi Zhang

  • Wei Wang

  • Qiaoli Li

  • Li Ye

  • Xinping Zhou

  • Lingxu Jiang

  • Liya Ma

  • Yingwan Luo

  • Hongyan Tong

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hematology

  • #2

    Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Hematology

Original Source(s)

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

  • by Yudi Zhang, Wei Wang, Qiaoli Li, Li Ye, Xinping Zhou, Lingxu Jiang, Liya Ma, Yingwan Luo, Hongyan Tong

  • May 29, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications